| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1999;118:270-275
© 1999 Mosby, Inc.
GENERAL THORACIC SURGERY |
From the Department of Thoracic Surgery, Hyogo Medical Center for Adults, Akashi City, Hyogo, Japan.
Address for reprints: Noriaki Tsubota, MD, Department of Thoracic Surgery, Hyogo Medical Center for Adults, Kitaohji-cho 13-70, Akashi City 673, Hyogo, Japan.
Objective: We analyzed the effect of the station of mediastinal metastasis with regard to the location of the primary tumor on the prognosis in patients with non–small cell lung cancer.
Methods: Of 956 consecutive patients who underwent operation for primary lung carcinoma between 1986 and 1996, 760 patients (79.5%) were diagnosed as having non– small cell carcinoma and were subjected to complete removal of hilar and mediastinal lymph nodes together with the primary tumor.
Results: The status of lymph node involvement was N0 in 480 patients (63.2%), N1 in 139 patients (18.3%), and N2 in 141 patients (18.6%). The 5- and 10-year survival of patients with N2 disease were 26% and 17%, respectively. Neither cell type nor the extent of procedure was a significant survival determinant. Patients having involvement of subcarinal nodes from upper-lobe tumors had a significantly worse prognosis than those patients with metastases only to the upper mediastinal or aortic nodes (P = .003). Patients with nodal involvement of the upper mediastinum from lower-lobe tumors had a significantly worse survival than those patients with metastases limited to the lower mediastinum (P = .039). Furthermore, patients with involvement of the aortic nodes alone from left upper-lobe tumors had a significantly better survival than those patients with metastasis to the upper or lower mediastinum beyond the aortic region (P = .044).
Conclusions: When mediastinal metastasis is limited to upper nodes from upper-lobe tumor, to lower nodes from lower-lobe tumor, or to aortic nodes from left upper-lobe tumor, acceptable survival could be expected after radical resection.
This article has been cited by other articles:
|
|
 |
|
  R. J. Cerfolio, A. S. Bryant, and M. A. Eloubeidi Accessing the Aortopulmonary Window (#5) and the Paraaortic (#6) Lymph Nodes in Patients With Non-Small Cell Lung Cancer Ann. Thorac. Surg., September 1, 2007; 84(3): 940 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Robinson, J. C. Ruckdeschel, H. Wagner Jr, and C. W. Stevens Treatment of Non-small Cell Lung Cancer-Stage IIIA: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 243S - 265S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nomori, K. Ikeda, T. Mori, H. Kobayashi, K. Iwatani, K. Kawanaka, S. Shiraishi, and T. Kobayashi Sentinel node navigation segmentectomy for clinical stage IA non-small cell lung cancer J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 780 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-P. Perng, C.-Y. Chen, G.-C. Chang, T.-C. Hsia, N.-Y. Hsu, Y.-H. Tsai, C.-M. Tsai, C.-H. Yang, Y.-M. Chen, C.-J. Yu, et al. Revisit of 1997 TNM Staging System--Survival Analysis of 1112 Lung Cancer Patients in Taiwan Jpn. J. Clin. Oncol., January 1, 2007; 37(1): 9 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Nechala, A. J. Graham, S. D. McFadden, S. C. Grondin, and G. Gelfand Retrospective Analysis of the Clinical Performance of Anterior Mediastinotomy Ann. Thorac. Surg., December 1, 2006; 82(6): 2004 - 2009. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. E. Lally, D. Zelterman, J. M. Colasanto, B. G. Haffty, F. C. Detterbeck, and L. D. Wilson Postoperative Radiotherapy for Stage II or III Non-Small-Cell Lung Cancer Using the Surveillance, Epidemiology, and End Results Database J. Clin. Oncol., July 1, 2006; 24(19): 2998 - 3006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, T. Sakamoto, T. Yuki, T. Mimura, K. Miyoshi, and N. Tsubota Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non-Small Cell Lung Cancer Ann. Thorac. Surg., March 1, 2006; 81(3): 1028 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, T. Sakamoto, T. Yuki, T. Mimura, H. Nitanda, K. Miyoshi, and N. Tsubota Border between N1 and N2 stations in lung carcinoma: Lessons from lymph node metastatic patterns of lower lobe tumors J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 825 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Keller, M. G. Vangel, H. Wagner, J. H. Schiller, A. Herskovic, R. Komaki, R. S. Marks, M. C. Perry, R. B. Livingston, and D. H. Johnson Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 130 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakagawa, Y. Minamiya, Y. Katayose, H. Saito, K. Taguchi, H. Imano, H. Watanabe, K. Enomoto, M. Sageshima, T. Ueda, et al. A novel method for sentinel lymph node mapping using magnetite in patients with non-small cell lung cancer J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 563 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sugi, Y. Kaneda, M. Sudoh, H. Sakano, and K. Hamano Effect of radioisotope sentinel node mapping in patients with cT1 N0 M0 lung cancer J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 568 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. Schmidt, E. A. Woltering, W. R. Webb, O. M. Garcia, J. E. Cohen, and M. H. Rozans Sentinel nodal assessment in patients with carcinoma of the lung Ann. Thorac. Surg., September 1, 2002; 74(3): 870 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nomori, H. Horio, T. Naruke, H. Orikasa, K. Yamazaki, and K. Suemasu Use of technetium-99m tin colloid for sentinel lymph node identification in non-small cell lung cancer J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 486 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Harewood, M. J. Wiersema, E. S. Edell, and M. Liebow Cost-Minimization Analysis of Alternative Diagnostic Approaches in a Modeled Patient With Non-Small Cell Lung Cancer and Subcarinal Lymphadenopathy Mayo Clin. Proc., February 1, 2002; 77(2): 155 - 164. [Abstract] [PDF]
|
|
|
|
|
|
D. Fang, D. Zhang, G. Huang, R. Zhang, L. Wang, and D. Zhang Results of surgical resection of patients with primary lung cancer: a retrospective analysis of 1,905 cases Ann. Thorac. Surg., October 1, 2001; 72(4): 1155 - 1159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Liptay, G. A. Masters, D. J. Winchester, B. L. Edelman, B. J. Garrido, T. R. Hirschtritt, R. M. Perlman, and W. A. Fry Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer Ann. Thorac. Surg., August 1, 2000; 70(2): 384 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka Induction Therapy for Non-small Cell Lung Cancer With Involved Mediastinal Nodes in Multiple Stations Chest, July 1, 2000; 118(1): 123 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, H. Yamagishi, S. Satake, H. Matsuoka, Y. Miyamoto, M. Yoshimura, and N. Tsubota SURVIVAL RELATED TO LYMPH NODE INVOLVEMENT IN LUNG CANCER AFTER SLEEVE LOBECTOMY COMPARED WITH PNEUMONECTOMY J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 814 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka How should interlobar pleural invasion be classified? prognosis of resected T3 non-small cell lung cancer Ann. Thorac. Surg., December 1, 1999; 68(6): 2049 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, H. Matsuoka, S. Satake, and H. Yamagishi EXTENDED SLEEVE LOBECTOMY FOR LUNG CANCER: THE AVOIDANCE OF PNEUMONECTOMY J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 710 - 714. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
